Oncogene

Article	Citations
Correction: Regulation of cancer stem cell activity by thyroid hormone receptor β	311
Identification of novel germline mutations in FUT7 and EXT1 linked with hereditary multiple exostoses	224
Correction: Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor	186
Correction to: Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential	124
Retraction Note: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells	118
Retraction Note: Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-α-Pix to Rac1 to activate the MAPK pathway	117
Vimentin intermediate filaments orchestrate DNA nonhomologous end joining repair and lipolysis after DNA damage	115
The hTERT-p50 homodimer inhibits PLEKHA7 expression to promote gastric cancer invasion and metastasis	109
Notch signaling regulates a metabolic switch through inhibiting PGC-1α and mitochondrial biogenesis in dedifferentiated liposarcoma	100
USP5 deubiquitinates and stabilizes IMPDH2, to promote hepatocellular carcinoma progression	99
Correction: DNA damage-induced translocation of mitochondrial factor HIGD1A into the nucleus regulates homologous recombination and radio/chemo-sensitivity	99
SCD5-dependent inhibition of SPARC secretion hampers metastatic spreading and favors host immunity in a TNBC murine model	97
Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells	96
GREB1 isoform 4 is specifically transcribed by MITF and required for melanoma proliferation	94
BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer	92
ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma	80
Correction: S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemia	79
A comprehensive analysis of LMO2 pathogenic regulatory profile during T-lineage development and leukemic transformation	77
LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer	75
RBMS3-loss impedes TRIM21-induced ubiquitination of ANGPT2 in an RNA-independent manner and drives sorafenib resistance in hepatocellular carcinoma	75
SOX10 deficiency-mediated LAMB3 upregulation determines the invasiveness of MAPKi-resistant melanoma	73
Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer	73
LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6/STAT3 signaling	71
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin	68
Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks	68

H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth	64
METTL3-mediated N6-methyladenosine modification of STAT5A promotes gastric cancer progression by regulating KLF4	64
tRF-33-P4R8YP9LON4VDP inhibits gastric cancer progression via modulating STAT3 signaling pathway in an AGO2-dependent manner	62
Downregulation of HINFP induces senescence-associated secretory phenotype to promote metastasis in a non-cell-autonomous manner in bladder cancer	62
SKAP2 suppresses inflammation-mediated tumorigenesis by regulating SHP-1 and SHP-2	61
Structure and function of MuvB complexes	60
RAD51-mediated homologous recombination is a pro-tumour driver pathway	59
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion	59
ALDH1A3 is the switch that determines the balance of ALDH+ and CD24−CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer	59
Deciphering glioma epitranscriptome: focus on RNA modifications	59
Gamma-glutamyltransferase 7 suppresses gastric cancer by cooperating with RAB7 to induce mitophagy	58
Increased antiandrogen enzalutamide sensitivity via altering prostate cancer stem cell traits through modulating the androgen receptor-mediated CDR1/circCDR1-AS/miR-1290/BMP4 signaling	58
MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex	58
Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells	57
RETRACTED ARTICLE: Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma	57
Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis	56
Hypoxia induces chemoresistance to proteasome inhibitors through orchestrating deSUMOylation and ubiquitination of SRC-3 in multiple myeloma	56
The lncRNA ST18-AS1 suppresses pancreatic cancer progression by enhancing ST18 mRNA stability through anchoring FUS in the cytoplasm	55
Editorial Expression of Concern: Role of BRCA1 in heat shock response	55
Retraction Note: Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis	55
Delactylase effects of SIRT1 on a positive feedback loop involving the H19-glycolysis-histone lactylation in gastric cancer	54
Pancreatic ductal adenocarcinoma induces neural injury that promotes a transcriptomic and functional repair signature by peripheral neuroglia	54
Membrane flexibility induced by BST2 contributes to radioresistance in glioblastoma	54
Recent insights into the causes and consequences of chromosome mis-segregation	53
The platelet pannexin 1-IL-1β axis orchestrates pancreatic ductal adenocarcinoma invasion and metastasis	53
The protection of UCK2 protein stability by GART maintains pyrimidine salvage synthesis for HCC growth under glucose limitation	53
RB loss determines selective resistance and novel vulnerabilities in ER-positive breast cancer models	52
CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype	51
NLRPs and tumor: research progress from molecular mechanisms to clinical applications	50
RBM8A confers oxaliplatin resistance in gastric cancer by maintaining EGFR mRNA stability	50
EGFR amplification and PI3K pathway mutations identify a subset of breast cancers that synergistically respond to EGFR and PI3K inhibition	49
PRSS23-eIF4E-c-Myc axis promotes gastric tumorigenesis and progression	49
Correction: MZF1 mediates oncogene-induced senescence by promoting the transcription of p16INK4A	48
Correction: HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium	48
Single-cell multiomics reveals a gene regulatory circuit driving leukemia cell differentiation	48
Correction: MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1	47
Correction: Editorial Expression of Concern: Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer	47
Correction to: Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance	47
Correction: Exosomal circCARM1 from spheroids reprograms cell metabolism by regulating PFKFB2 in breast cancer	47
STT3A-mediated viral N-glycosylation underlies the tumor selectivity of oncolytic virus M1	46
Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263	45
Induction of IL6/STAT3-dependent TRAIL expression that contributes to the therapeutic efficacy of osimertinib in EGFR mutant NSCLC cells	45
Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis	45
Correction to: EphA2–YES1–ANXA2 pathway promotes gastric cancer progression and metastasis	44
Correction: An FGFR-p53 developmental signaling axis drives salivary cancer progression	44
Revealing the tumor suppressive sequence within KL1 domain of the hormone Klotho	44
Transferrin receptor 1 promotes the fibroblast growth factor receptor-mediated oncogenic potential of diffused-type gastric cancer	44
Extracellular vesicles of cancer cells induce FOXP3+ fibroblasts and facilitate tumor invasion via the Wnt3-β-catenin pathway	44
CircKDM4B suppresses breast cancer progression via the miR-675/NEDD4L axis	44
Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC	43

PABPN1-C5 axis promotes hepatocellular carcinoma progression via NF-κB activation	43
Alternative splicing in prostate cancer progression and therapeutic resistance	43
RIOK1 mediates p53 degradation and radioresistance in colorectal cancer through phosphorylation of G3BP2	42
Post-transcriptional control of gene expression by β-catenin: expanding the non-canonical ARMoury	42
Correction to: Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1	42
Tumor cell-derived ANGPTL2 promotes β-catenin-driven intestinal tumorigenesis	41
ROS production by mitochondria: function or dysfunction?	41
Inhibition of multiple CDKs potentiates colon cancer chemotherapy via p73-mediated DR5 induction	41
AGO4 suppresses tumor growth by modulating autophagy and apoptosis via enhancing TRIM21-mediated ubiquitination of GRP78 in a p53-independent manner	41
AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors	41
RNA-sequencing predicts a role of androgen receptor and aldehyde dehydrogenase 1A1 in osteosarcoma lung metastases	41
Correction to: Long non-coding RNA KRT19P3 suppresses proliferation and metastasis through COPS7A-mediated NF-κB pathway in gastric cancer	40
Correction: Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours	40
Correction: PLK1 inhibition selectively induces apoptosis in ARID1A deficient cells through uncoupling of oxygen consumption from ATP production	40
Tumor-mesothelium HOXA11-PDGF BB/TGF β1-miR-181a-5p-Egr1 feedforward amplifier circuity propels mesothelial fibrosis and peritoneal metastasis of gastric cancer	40
Correction: NFκB activation by hypoxic small extracellular vesicles drives oncogenic reprogramming in a breast cancer microenvironment	40
The sodium channel subunit SCNN1B suppresses colorectal cancer via suppression of active c-Raf and MAPK signaling cascade	40
Mesenchymal stromal cells confer breast cancer doxorubicin resistance by producing hyaluronan	39
Decoding the adaptive survival mechanisms of breast cancer dormancy	39
Correction: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E	39
Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype	39
Correction: ROR1-targeting switchable CAR-T cells for cancer therapy	39
Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma	38
RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition	38
Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress tolerance	37
Stabilization of MOF (KAT8) by USP10 promotes esophageal squamous cell carcinoma proliferation and metastasis through epigenetic activation of ANXA2/Wnt signaling	37
Cyclin E1 overexpression sensitizes ovarian cancer cells to WEE1 and PLK1 inhibition	37
OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer	37
YBX1 promotes 5-Fluorouracil resistance in gastric cancer via m5C-dependent ATG9A mRNA stabilization through autophagy	37
The influence of endothelial metabolic reprogramming on the tumor microenvironment	36
OLFM4 deficiency delays the progression of colitis to colorectal cancer by abrogating PMN-MDSCs recruitment	36
PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer	36
SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity	36
Hepatitis B virus X protein promotes the progression and immune escape of hepatocellular carcinoma by activating KLF16-C12orf49-PD-L1 axis	36
BRD4 regulates PAI-1 expression in tumor-associated macrophages to drive chemoresistance in colorectal cancer	36
Ac4C modification of lncRNA SIMALR promotes nasopharyngeal carcinoma progression through activating eEF1A2 to facilitate ITGB4/ITGA6 translation	36
E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer	36
Phosphorylation of USP27X by PIM2 promotes glycolysis and breast cancer progression via deubiquitylation of MYC	35
Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis	35
SIRT7: a novel molecular target for personalized cancer treatment?	35
Engineering prostate cancer in vitro: what does it take?	35
Enhanced anti-cancer efficacy of arginine deaminase expressed by tumor-seeking Salmonella Gallinarum	35
Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex	35
C4orf19 inhibits colorectal cancer cell proliferation by competitively binding to Keap1 with TRIM25 via the USP17/Elk-1/CDK6 axis	35
METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability	35
Feedback activation of EGFR/wild-type RAS signaling axis limits KRASG12D inhibitor efficacy in KRASG12D-mutated colorectal cancer	35
MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances	34
Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis	34
Inactivation of EGLN3 hydroxylase facilitates Erk3 degradation via autophagy and impedes lung cancer growth	34
The kinesin KIF20A promotes progression to castration-resistant prostate cancer through autocrine activation of the androgen receptor	34
Correction: Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma	34
Correction: Loss-of-function mutations of SOX17 lead to YAP/TEAD activation-dependent malignant transformation in endometrial cancer	33
Correction: IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma	33
Retraction Note: Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor	33
Molecular explorations of cancer biology and therapeutics at PDB-101	33
Correction to: Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55	33
Retraction Note: Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1α levels contribute to emergence of an aggressive phenotype in prostat	33
Shallow whole genome re-sequencing to precisely predict benefit from PARP inhibitor	32
Lysine metabolism is a novel metabolic tumor suppressor pathway in breast cancer	32
Editorial Expression of Concern: Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress	32
Correction: The ELF3-regulated lncRNA UBE2CP3 is over-stabilized by RNA–RNA interactions and drives gastric cancer metastasis via miR-138-5p/ITGA2 axis	32
Editorial Expression of Concern: Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene	32
Single-cell landscape of undifferentiated pleomorphic sarcoma	31
Long non-coding RNA-MIR181A1HG acts as an oncogene and contributes to invasion and metastasis in gastric cancer	31
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer	30
sEV-mediated intercellular transformation from MGAT4AHigh to MGAT4ALow tumor cells via the HOTAIRM1/miR-196b-5p axis promotes apoptosis resistance in CTCL	30
The deubiquitinase OTUD1 orchestrates cisplatin chemosensitivity of non-small cell lung cancer through destabilizing RAD23B/XPC	30
CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression	30
HJURP is recruited to double-strand break sites and facilitates DNA repair by promoting chromatin reorganization	30
circIPO7 dissociates caprin-1 from ribosomes and inhibits gastric cancer cell proliferation by suppressing EGFR and mTOR	30
Correction: Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms	30
Retraction Note: Synergy between arsenic trioxide and JQ1 on autophagy in pancreatic cancer	30
Celastrol recruits UBE3A to recognize and degrade the DNA binding domain of steroid receptors	30
Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1	30
Zinc ions activate AKT and promote prostate cancer cell proliferation via disrupting AKT intramolecular interaction	30
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma	29
Leveraging RAS-mSIN1 interaction to selectively inhibit mTORC2 employing competitive RAS binding peptide: implications in breast cancer metastasis	29
PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3	29
LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and TSC2 ubiquitination	29
USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer	29

Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib	29
KDM1A-driven RNF81 downregulation promotes gastric cancer progression via KLF4 destabilization	29
Phosphorylation of FOXK2 at Thr13 and Ser30 by PDK2 sustains glycolysis through a positive feedback manner in ovarian cancer	29
CircVPS8 promotes the malignant phenotype and inhibits ferroptosis of glioma stem cells by acting as a scaffold for MKRN1, SOX15 and HNF4A	29
Hesperadin suppresses pancreatic cancer through ATF4/GADD45A axis at nanomolar concentrations	28
Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner	28
The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review	28
Comprehensive single-cell analysis reveals mast cells’ roles in cancer immunity	28
Correction: Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi’s sarcoma development	28
Clustering single-cell RNA sequencing data via iterative smoothing and self-supervised discriminative embedding	28
The role of miR-92b-3p in notch signaling and monitoring of oral squamous cell carcinoma	28
Selective inhibition of CDK9 in triple negative breast cancer	28
A proof of concept for targeting the PrPC - Amyloid β peptide interaction in basal prostate cancer and mesenchymal colon cancer	28
O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation	28
The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation	27
ARHGAP–RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer	27
Retraction Note: Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer	27
Targeting SREBP-dependent lipogenesis potentiates the anti-tumor activity of docetaxel by increasing membrane permeability and intracellular drug accumulation	27
The proteomic characterization of the peritumor microenvironment in human hepatocellular carcinoma	27
Retraction Note: E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage	27
Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma	27
The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review	27
A multi-faceted discovery strategy identifies functional antibodies binding to cysteine-rich domain 1 of hDKK1 for cancer immunotherapy via Wnt non-canonical pathway	27
Editorial Expression of Concern: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer	27
ScRNA-seq of gastric cancer tissues reveals differences in the immune microenvironment of primary tumors and metastases	26
Correction: Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma	26
JAK2/ULK1 axis promotes cervical cancer progression by autophagy induction and SRPK1 phosphorylation	26
Suppression of mutant Kirsten-RAS (KRASG12D)-driven pancreatic carcinogenesis by dual-specificity MAP kinase phosphatases 5 and 6	26
VprBP/DCAF1 regulates p53 function and stability through site-specific phosphorylation	26
NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation	26
Importin-alpha transports Norrin to the nucleus to promote proliferation and Notch signaling in glioblastoma stem cells	26
Pan-RAS inhibitors and polo-like kinase 1: promising targets in colorectal cancer	26
Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer	26
Appearance of tuft cells during prostate cancer progression	25
Nuclear FGFR1 promotes pancreatic stellate cell-driven invasion through up-regulation of Neuregulin 1	25
Origin and Evolution of RAS Membrane Targeting	25
Correction: GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90	25
Of travelling homeoproteins and medulloblastomas	25
Alcohol-driven metabolic reprogramming promotes development of RORγt-deficient thymic lymphoma	25
Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis	25
A novel integrated approach to predicting cancer immunotherapy efficacy	25
Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence	25
Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancer	25
GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma	25
Protein disulfide isomerase-enriched extracellular vesicles from bladder cancer cells support tumor survival and malignant transformation in the bladder	25
WTAP-mediated m6A methylation of PHF19 facilitates cell cycle progression by remodeling the accessible chromatin landscape in t(8;21) AML	25
DMT1-dependent endosome-mitochondria interactions regulate mitochondrial iron translocation and metastatic outgrowth	25
PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer	24
Integrative metabolomic characterization identifies plasma metabolomic signature in the diagnosis of papillary thyroid cancer	24
Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma	24
The role of α-klotho in human cancer: molecular and clinical aspects	24
M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription	24
RNF126-mediated ubiquitination of FSP1 affects its subcellular localization and ferroptosis	24
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers	24
GNAO1 overexpression promotes neural differentiation of glioma stem-like cells and reduces tumorigenicity through TRIM21/CREB/HES1 axis	24
A novel lncRNA MTAR1 promotes cancer development through IGF2BPs mediated post-transcriptional regulation of c-MYC	24
Ubiquitin and ubiquitin-like proteins in HPV-driven carcinogenesis	24
RETRACTED ARTICLE: Targeting HIF-1α/NOTCH1 pathway eliminates CD44+ cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma	24
Loss of deubiquitylase USP2 triggers development of glioblastoma via TGF-β signaling	24
CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis	24
Correction: TSPAN6 is a suppressor of Ras-driven cancer	24
Editorial Expression of Concern: RING finger-dependent ubiquitination by PRAJA is dependent on TGF-ß and potentially defines the functional status of the tumor suppressor ELF	23
SMARCE1 promotes neuroblastoma tumorigenesis through assisting MYCN-mediated transcriptional activation	23
Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program	23
Correction: Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway	23
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer	23
Persistent organic pollutants promote aggressiveness in prostate cancer	23
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer	23
circSETD3 confers radiotherapy resistance in nasopharyngeal carcinoma by attenuating ER stress-induced autophagy and apoptosis via PDIA6 upregulation	23
Subsets of cancer cells expressing CX3CR1 are endowed with metastasis-initiating properties and resistance to chemotherapy	23
EphA2 regulates vascular permeability and prostate cancer metastasis via modulation of cell junction protein phosphorylation	23
Amyloid-like p53 as prognostic biomarker in serous ovarian cancer—a study of the OVCAD consortium	23
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis	23
Epigenetics behind tumor immunology: a mini review	23
GDP-mannose 4,6-dehydratase is a key driver of MYCN-amplified neuroblastoma core fucosylation and tumorigenesis	23
Effect of TGF-β mediated phenotypic changes on prostate cancer cell anoikis response	23
Targeting RBM39 suppresses tumor growth and sensitizes osteosarcoma cells to cisplatin	23
Correction: Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma	23
GPER-mediated stabilization of HIF-1α contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells	23
Exosomal circSPIRE1 mediates glycosylation of E-cadherin to suppress metastasis of renal cell carcinoma	23
M7G modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma	23
HMGB1/SET/HAT1 complex-mediated SASH1 repression drives glycolysis and metastasis in lung adenocarcinoma	23
Ten years of oncogene editorship: a decade of transformation	23
Spatial collagen stiffening promotes collective breast cancer cell invasion by reinforcing extracellular matrix alignment	22
TWIST1 is a critical downstream target of the HGF/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer	22
CRL2KLHDC3 and CRL1Fbxw7 cooperatively mediate c-Myc degradation	22
Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment	22
JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3/IL-10 axis	22
Correction: Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL	22
Glucose-mediated N-glycosylation of RPTPα affects its subcellular localization and Src activation	22
Retraction Note: Activation of caspase-9 with irradiation inhibits invasion and angiogenesis in SNB19 human glioma cells	22
Circulating extracellular vesicles protein expression for early prediction of platinum-resistance in high-grade serous ovarian cancer	22
Correction: Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance	22
RUVBL1 promotes enzalutamide resistance of prostate tumors through the PLXNA1-CRAF-MAPK pathway	22
Nuclear translocation of Gasdermin D sensitizes colorectal cancer to chemotherapy in a pyroptosis-independent manner	22